Home : Unsafe Drugs : Singulair : News Articles
Singulair - News Articles
-
Monday, August 04, 2008
Pharma Times (subscription), UK -
Schering-Plough has suffered a major blow with the news that US regulators have rejected its anaesthesia compound sugammadex, just months after being recommended for approval. The US Food and Drug Administration has issued a ‘not-approvable’ letter for Bridion (sugammadex), an ... -
Aug 2, 2008
Boston Globe, United States -
NEW YORK (Reuters) - Schering-Plough Corp said on Friday US regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts and was unanimously recommended by a federal advisory panel. ... -
Aug 2, 2008
Minneapolis Star Tribune, MN -
By MATTHEW PERRONE , AP WASHINGTON - Government regulators dealt a major setback to Schering-Plough Corp., rejecting a highly anticipated drug designed to help patients recover from anesthesia. The Food and Drug Administration notified the company Thursday that it will not ... -
Jul 31, 2008
Science Magazine (subscription) -
Neuroimaging, high-tech materials, new asthma meds, detection-eluding drugs, thermoregulation--will all these make athletes stronger and faster at the 2008 ... -
Sunday, August 03, 2008
Olympic -
Athletes participating in the Beijing 2008 Olympic Games will donate sporting clothes for refugees in Asia. The IOC and the United Nations High Commissioner for Refugees explains: "Refugee youth have often suffered terribly and witnessed war first hand. Some refugees are born in ... -
Saturday, August 02, 2008
California Job Journal, CA -
Review Major depression, xanax. Xenical hgh phentermine online no prescription pharmacy discounter! In some we invite you to tell your life! ... -
Sunday, August 03, 2008
California Job Journal, CA -
It is not generic ambien at our pharmacy. Ambien is indicated for for sale. Bextra outweighed Bextra be monitored during treatment. ... -
Jul 31, 2008
Science Magazine (subscription) -
Neuroimaging, high-tech materials, new asthma meds, detection-eluding drugs, thermoregulation--will all these make athletes stronger and faster at the 2008 ... -
Friday, August 01, 2008
NPR -
Day to Day, August 1, 2008 · Air quality in Beijing has been improving steadily since July 26, says University of Rhode Island atmospheric chemist Kenneth Rahn. Rahn, who plots the daily air quality in Beijing, decodes "blue sky days" and other measures of air ... -
Friday, August 01, 2008
domain-B, India -
Mumbai: The US Food and Drug Administration (FDA) has rejected Schering-Plough Corporatin's new anesthesia product Sugammadex, saying the drug designed to undo the affects of muscle relaxants after surgeries, was non-approvable. FDA has issued a ''non-approvable" letter for ...
-
Friday, August 01, 2008
RTT News, NY -
(RTTNews) - Global health care company Schering-Plough Corp. (SGP: News, Chart, Quote ) said Friday that the US Food and Drug Administration issued a "not-approvable" letter for sugammadex sodium injection for the reversal of muscle relaxation during general anesthesia. Thomas Koestler, Executive ... -
Friday, August 01, 2008
Abkhazia, CA -
European regulators have approved a breakthrough new medication to help patients emerge far more quickly from anesthesia than existing treatments, the drug's maker Schering-Plough Corp said on Tuesday. The drug, called Bridion, was approved by the European Commission, ... -
Friday, August 01, 2008
Earthtimes (press release), UK -
KENILWORTH, NJ , Aug. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the US Food and Drug Administration (FDA) has ... -
Friday, August 01, 2008
RTT News, NY -
(RTTNews) - Schering-Plough (SGP: News, Chart, Quote ) fell in pre-market trading, down nearly 8%. The drop came after the company received a not-approvable letter for sugammadex sodium injection for the reversal of muscle relaxation during general anesthesia. It is to be noted ... -
Friday, August 01, 2008
Pharmalot, NJ -
By Ed Silverman // August 1st, 2008 // 10:45 am The rejection of Bridion, a drug developed to reverse the effects of anesthesia, is the latest setback for the drugmaker, which is still reeling over the controversy and subsequent loss in revenue from its Vytorin cholesterol pill. ... -
Friday, August 01, 2008
NJBIZ, NJ -
Kenilworth-based Schering-Plough Corp. (NYSE: SGP) said today that the US Food and Drug Administration has issued a "not-approvable" letter for sugammadex, ... -
Friday, August 01, 2008
Lifescience-online, Switzerland -
Schering-Plough Corporation today announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA), is the first major pharmaceutical advance in the field of anesthesia in two decades. It ... -
Friday, August 01, 2008
Forbes, NY -
AP 08.01.08, 8:06 AM ET Shares of drug maker Schering-Plough Corp. fell in premarket trading Friday following the Food and Drug Administration's surprise ... -
Friday, August 01, 2008
CNNMoney.com -
NEW YORK (AP)_ Shares of drug maker Schering-Plough Corp. fell in premarket trading Friday following the Food and Drug Administration's surprise rejection ... -
Friday, August 01, 2008
Wall Street Journal -
By KEVIN KINGSBURY The Food and Drug Administration issued a non-approvable letter to Schering-Plough Corp. for its drug designed to undo the affects of ...
Pages: Previous 1 2 3 4 5 6 7 ... Next






